Clinical Trials Directory

Trials / Completed

CompletedNCT02750722

Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis

Acute Effects of Combined Exercise and Oscillatory Positive Expiratory Pressure Therapy on Sputum Properties and Lung Diffusion Capacity in Cystic Fibrosis: a Randomized Crossover Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to compare a single bout of moderately intense cycling exercise incorporating Flutter® breathing maneuvers with a single bout of moderately intense cycling exercise alone on sputum viscoelasticity (primary endpoint) and the diffusion capacity of the lungs in adult patients with cystic fibrosis. The investigators further aim to analyze the short-term variability of resting diffusion capacity of carbon monoxide (DLCO) and nitric oxide (DLNO) in patients with cystic fibrosis.

Detailed description

Regular airway clearance is an integral component of cystic fibrosis care and of critical importance to lung health. Exercise and standardized chest physiotherapy are accepted airway clearance techniques in cystic fibrosis. Different airway clearance techniques are available, but there is no evidence that one technique or a combination is superior. Oscillatory positive expiratory pressure with the Flutter® is a widely used airway clearance technique in the European countries and has been shown to favourably alter sputum viscoelasticity in cystic fibrosis. This randomized crossover study is designed to assess the acute effects of combined cycling exercise and Flutter® therapy on sputum viscoelasticity (primary outcome measure) and gas diffusion in adults with cystic fibrosis.

Conditions

Interventions

TypeNameDescription
DEVICEFlutter®Acute exercise with Flutter® breathing therapy.
DEVICENo Flutter®Acute exercise without Flutter® breathing therapy.

Timeline

Start date
2016-05-01
Primary completion
2017-01-19
Completion
2017-01-19
First posted
2016-04-25
Last updated
2017-01-25

Locations

3 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02750722. Inclusion in this directory is not an endorsement.